Back to Podcast
A Path to the First FDA Drug for Concussion? How Ghrelin Could Change Brain Injury Recovery with Dr. Vishal Bansal | E56
April 27, 202632m 06s
ResearchNeuroinflammation
About This Episode
Could ghrelin — a hormone best known for regulating hunger — become the first FDA-approved drug for concussion? In this episode, Dr. Ayla Wolf speaks with Dr. Vishal Bansal of Oxeia Biopharmaceuticals about the cutting-edge research exploring ghrelin's role in brain injury recovery.
Dr. Bansal shares the science behind ghrelin and the brain, the clinical trials underway, and what this could mean for the millions of people living with post-concussion syndrome and TBI who currently have no pharmaceutical options approved specifically for their condition.
Topics Covered
ResearchNeuroinflammation
Full Transcript
Dr. Vishal Bansal: 00:00
And the idea is to then prevent symptoms from developing down the road rather than treating the symptoms that are actually occurring. I think ghrelin can work in both ways because the effects that ghrelin has, hormones are pluotrophic. They have multiple effects. And one of the effects that ghrelin has on the brain is in the immediate phase, it can really restore mitochondrial health, it can decrease reaction to oxygen species. And in the longer term, it can really have a direct effect of the hippocampus and the axons. And I think that's why we can see a dual effect of ghrelin for concussions, both in the immediate period and the subimmediate period.
Dr. Ayla Wolf: 00:33
Welcome to Life After Impact, the concussion recovery podcast. I'm Dr. Ayla Wolf, and I will be hosting today's episode where we help you navigate the often confusing, frustrating, and overwhelming journey of concussion and brain injury recovery. This podcast is your go-to resource for actionable information, whether you're dealing with a recent concussion, struggling with post-concussion syndrome, or just feeling stuck in your healing process. In each episode, we dive deep into the sympto…